Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease

Blood

Volumn 91, Issue 11, 1998, Pages 4216-4223

  Key, Nigel S ^a   Slungaard, Arne ^b   Dandelet, Luke ^b   Nelson, Stephen C ^b   Moertel, Christopher ^b   Styles, Lori A ^b   Kuypers, Frans A ^b   Bach, Ronald R ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7A; THROMBOPLASTIN;

ARTICLE; BLOOD CLOTTING; DIAGNOSTIC VALUE; HUMAN; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DETERMINATION; SICKLE CELL ANEMIA;

EID: 0032101042     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.11.4216.411k15_4216_4223     Document Type: Article

References (42)

1. Berney SI, Ridler CD, Stephens AD, Thomas AE, Kovacs IB: Enhanced platelet reactivity and hypercoagulability in the steady state of sickle cell anemia. Am J Hematol 40:290, 1992
2. Triadou P, Fonty E, Ambrosio AS, Cottat MC, Girot R, Cornu P: Platelet function in sickle cell disease during steady state. Nouv Rev Fr Hematol 32:137, 1990
3. Hagger D, Wolff S, Owen J, Samson D: Changes in coagulation and fibrinolysis in patients with sickle cell disease compared with healthy black controls. Blood Coagul Fibrinolysis 6:93, 1995
4. Peters M, Plaat BE, ten Cate H, Wolters HJ, Weening RS, Brandjes DP: Enhanced thrombin generation in children with sickle cell disease. Thromb Haemost 71:169, 1994
5. Francis RB: Elevated fibrin D-dimer fragment in sickle cell anemia: Evidence for activation of coagulation during the steady state as well as in pain crisis. Haemostasis 19:105, 1989
6. Alkjaersig N, Fletcher A, Joist H, Chaplin H: Hemostatic alterations accompanying sickle cell pain crisis. J Lab Clin Med 88:440, 1976
7. Francis RB Jr, Johnson CS: Vascular occlusion in sickle cell disease: Current concepts and unanswered questions. Blood 77:1405, 1991
8. Francis RB Jr: Platelets, coagulation, and fibrinolysis in sickle cell disease: Their possible role in vascular occlusion. Blood Coagul Fibrinolysis 2:341, 1991
9. Green D, Scott JP: Is sickle cell crisis a thrombotic event? Am J Hematol 23:317, 1986
10. Seligsohn U, Osterud B, Brown SF, Griffin JH, Rapaport SI: Activation of human factor VII in plasma and in purified systems: Roles of activated factor IX, kallikrein, and activated factor XII. J Clin Invest 64:1056, 1979
11. Nemerson Y, Repke D: Tissue factor accelerates the activation of coagulation factor VII: The role of a bifunctional coagulation cofactor. Thromb Res 40:351, 1985
12. Wildgoose P, Nemerson Y, Hansen LL, Nielsen FE, Glazer S, Hedner U: Measurement of basal levels of factor VIIa in hemophilia A and B patients. Blood 80:25, 1992
13. Drake TA, Morrissey JH, Edgington TS: Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 134:1087, 1989
14. Wilcox JN, Smith KM, Schwartz SM, Gordon D: Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 86:2839, 1989
15. Nawroth PP, Handley DA, Esmon CT, Stern DM: Interleukin-1 induces endothelial cell procoagulant while suppressing cell surface anticoagulant activity. Proc Natl Acad Sci USA 83:3460, 1986
16. Conkling PR, Greenberg CS, Weinberg JB: Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U937 and peripheral mononcytes. Blood 72:128, 1988
17. Cermak J, Key NS, Bach RR, Balla J, Jacob HS, Vercellotti GM: C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 82:513, 1993
18. Kurantsin-Mills J, Ofosu FA, Safa TK, Siegel RS, Lessin LS: Plasma factor VII and thrombin-antithrombin III levels indicate increased tissue factor activity in sickle cell patients. Br J Haematol 81:539, 1992
19. Bach R, Konigsberg WH, Nemerson Y: Human tissue factor contains thioester-linked palmitate and stearate on the cytoplasmic half-cystine. Biochemistry 27:4227, 1988
20. Morrissey JH, Macik BG, Neuenschwander PF, Comp PC: Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 81:734, 1993
21. Lindahl AK, Abilgaard U, Larsen ML, Staalsen R, Kari A, Hammer G, Sandset PM, Nordfang O, Beck TC: Extrinsic pathway inhibitor (EPI) released to the blood by heparin is a more powerful coagulation inhibitor than is recombinant EPI. Thromb Res 62:607, 1991
22. Carson SD, Ross SE, Bach R, Guha A: An inhibitory monoclonal against human tissue factor. Blood 70:490, 1987
23. Bloem LJ, Chen L, Konigsberg WH, Bach R: Serum stimulation of quiescent human fibroblasts induces the synthesis of tissue factor mRNA followed by the appearance of tissue factor antigen and procoagulant activity. J Cell Physiol 139:418, 1989
24. Osterud B, Eskeland T: The mandatory role of complement in the endotoxin-induced synthesis of tissue thromboplastin in blood monocytes. FEBS Lett 149:75, 1982
25. Osterud B: The high responder phenomenon: Enhancement of LPS-induced tissue factor activity in monocytes by platelets and granulocytes. Platelet 6:119, 1995
26. West MS, Wethers D, Smith J, Steinberg M, and the Cooperative Study of Sickle Cell Disease: Laboratory profile of sickle cell disease. J Clin Epidemiol 45:893, 1992
27. Morrissey JH: Tissue factor interactions with factor VII: Measurement and clinical significance of factor VIIa in plasma. Blood Coagul Fibrinolysis 6:S14, 1995
28. Lawson JH, Butenas S, Ribarik N, Mann KG: Complex-dependent inhibition of factor VIIa by antithrombin III and heparin. J Biol Chem 268:767, 1993
29. Nemerson Y: The tissue factor pathway of blood coagulation, in Colman RW, Hirsch J, Marder VJ, Salzman EW (eds): Hemostasis and Thrombosis: Basic Principles and Clinical Practice (ed 3). Philadelphia, PA, Lipincott, 1994, p 81
30. Semeraro N, Colucci M: Tissue factor in health and disease. Thromb Haemost 78:759, 1997
31. Sowemimo-Coker SO, Meiselman HJ, Francis RB Jr: Increased circulating endothelial cells in sickle cell crisis. Am J Hematol 31:263, 1989
32. Solovey A, Lin Y, Key NS, Hebbel RP: Tissue factor expression by endothelial cells in sickle cell anemia. J Clin Invest (in press)
33. Drake TA, Ruf W, Morrissey JH, Edgington TS: Functional tissue factor is entirely cell surface expressed on lipopolysaccharide-stimulated human blood monocytes and a constitutively tissue factor-producing neoplastic cell line. J Cell Biol 109:389, 1989
34. Bach R, Rifkin DB: Expression of tissue factor procoagulant activity: Regulation by cytosolic calcium. Proc Natl Acad Sci USA 87:6995, 1990
35. Bach RR, Moldow CF: Mechanism of tissue factor activation on HL-60 cells. Blood 89:3270, 1997
36. Francis RB, Haywood LJ: Elevated immunoreactive tumor necrosis factor and interleukin-1 in sickle cell disease. J Natl Med Assoc 84:611, 1992
37. Akinola NO, Stevens SME, Franklin IM, Nash GB, Stuart J: Rheological changes in the prodromal and established phases of sickle cell vaso-occlusive crises. Br J Haematol 81:598, 1992
38. Akinola NO, Stevens SME, Franklin IM, Nash GB, Stuart J: Subclinical ischaemic episodes during the steady state of sickle cell anaemia. J Clin Pathol 45:902, 1992
39. Singhal A, Doherty JF, Raynes JG, McAdam KPWJ, Thomas PW, Serjeant BE, Serjeant GR: Is there an acute phase response in steady-state sickle cell disease? Lancet 341:651, 1993
40. Li A, Morrissey J, Chang AKC, Peer G, Taylor FB: Factors VIIc and VIIa plasma concentrations are depressed following bolus injection of endotoxin into normal human subjects. Blood 88:443a, 1996 (abstr, suppl 1)
41. Mesters RM, Mannucci PM, Coppola R, Keller T, Osterman H, Kienast J: Factor VIIa and antithrombin III activity during severe sepsis and septic shock in neutropenic patients. Blood 88:881, 1996
42. Sandset PM, Bendz B: Tissue factor pathway inhibitor: Clinical deficiency states. Thromb Haemost 78:467, 1997